Diagnosing Burkitt Lymphoma in Sub-Saharan Africa by Sequencing of Circulating Tumour DNA: a Comparative Microcosting Study
MORRELL L. et al, (2025), Value in Health Regional Issues
Rituximab for children with EBV-positive Burkitt lymphoma in East Africa.
Mawalla WF. et al, (2025), Blood Adv
Multimodal cell-free DNA whole-genome TAPS is sensitive and reveals specific cancer signals.
Vavoulis DV. et al, (2025), Nat Commun, 16
A Systematic Approach to Prioritise Diagnostically Useful Findings for Inclusion in Electronic Health Records as Discrete Data to Improve Clinical Artificial Intelligence Tools and Genomic Research.
Guillod P. et al, (2024), Clin Oncol (R Coll Radiol), 39
Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis.
Schoenpflug LA. et al, (2024), J Pathol
Applications of Nanopore sequencing in precision cancer medicine.
Dyshlovoy SA. et al, (2024), Int J Cancer, 155, 2129 - 2140
Effect of Compression Dressing After Upper Eyelid Blepharoplasty on Edema, Ecchymosis, Pain, and Ocular Surface Irritation.
Schuh A. et al, (2024), Ophthalmic Plast Reconstr Surg, 40, 627 - 633
Telomere length and DNA methylation epitype both provide independent prognostic information in CLL patients; data from the UK CLL4, ARCTIC and ADMIRE clinical trials.
Carr L. et al, (2024), Br J Haematol, 205, 2072 - 2076
[Enucleations, eviscerations and orbital implants in German eye hospitals].
Schuh A. et al, (2024), Ophthalmologie, 121, 814 - 820
Large-scale analysis of whole genome sequencing data from formalin-fixed paraffin-embedded cancer specimens demonstrates preservation of clinical utility.
Basyuni S. et al, (2024), Nat Commun, 15
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.
Westenberger A. et al, (2024), Brain, 147, 2652 - 2667
The impact of inversions across 33,924 families with rare disease from a national genome sequencing project.
Pagnamenta AT. et al, (2024), Am J Hum Genet, 111, 1140 - 1164
What is new in the 5th edition of the World Health Organization classification of mature B and T/NK cell tumors and stromal neoplasms?
Attygalle AD. et al, (2024), J Hematop, 17, 71 - 89
Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML.
Risueño A. et al, (2024), Leuk Res, 140
The 5th edition of the World Health Organization Classification of mature lymphoid and stromal tumors - an overview and update.
Attygalle AD. et al, (2024), Leuk Lymphoma, 65, 413 - 429
Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia.
Murphy T. et al, (2024), Haematologica, 109, 671 - 675
Presentation of Graves' orbitopathy within European Group On Graves' Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III).
Schuh A. et al, (2024), Br J Ophthalmol, 108, 294 - 300
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
Munir T. et al, (2024), N Engl J Med, 390, 326 - 337
Utility of glass slide morphology (GSM) and whole slide image (WSI) in the diagnosis of acute leukemia (AL) by types.
Iddy H. et al, (2024), Ecancermedicalscience, 18